Page 5
Introduction to Breast Cancer Breast cancer (BC) stands as the most diagnosed malignancy among women, significantly impacting global health.1, 2 In 2018, it was estimated that approximately 2.1…
Introduction: Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone marrow. MM manifests clinically as hypercalcaemia, renal failure,…
In October 2023, the 16th European Nursing of Oncology Society’s Conference (EONS16), ‘Cancer nursing: Building on innovation and building back better in healthcare’ took place in Madrid. The…
Pancreatic Cancer: A Tough Nut to Crack! Pancreatic cancer presents a significant clinical challenge. Currently, the 5-year survival rate for patients diagnosed with this cancer is only 12%,…
Introduction to Homologous Recombination Deficiency Homologous recombination deficiency (HRD) represents a pivotal concept in oncology, characterized by a functional loss in the homologous recombination repair (HRR) pathway. Essential…
Currently there are over 200,000 people living with and beyond cancer in Ireland and that number is expected to double over the next 25 years. Approximately 10% of…
Prof Seamus O’Reilly BSc MD PhD FRCPI is Consultant Medical Oncologist at Cork-Mercy and South Infirmary Victoria University Hospitals, Clinical Lead at Cancer Trials Ireland, and Clinical Professor…
November was global lung cancer awareness month. As part of its annual awareness campaign, the Irish Cancer Society (the Society) highlighted the importance of early detection and the…
BRCA stands for BReast CAncer gene. BRCA1 and BRCA2 are tumour suppressor genes which means that they stop the cells in our body from growing and dividing out…
Penile cancer is a rare male genital cancer which presents in older men in the 6th or 7th decades. However, the disease is not limited to the older…
You’re all caught up.
